# A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants

> **NCT06126835** · — · ACTIVE_NOT_RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 2828 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Ozanimod
- **DRUG:** Conventional therapy
- **DRUG:** Advanced therapy

## Key facts

- **NCT ID:** NCT06126835
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-26
- **Primary completion:** 2031-05-31
- **Final completion:** 2032-06-30
- **Target enrollment:** 2828 (ESTIMATED)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06126835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06126835, "A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06126835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*